Moreover, metallothionein, a potent antioxidant [58], was identified to be a downstream target of Nrf2 and predominantly mediated SFN's protective effects on diabetic nephropathy [18] and DCM [31]. The gene discussed is NFE2L2; the disease is familial dilated cardiomyopathy.